อ่านเพิ่มเติม
00:08 · 7 āļ•āļļāļĨāļēāļ„āļĄ 2023

Aehr Test Systems loses 14% despite record fiscal Q1 earnings 📉

-
-
Open account Download free app

Shares of Aehr Systems (AEHR.US) are trading down 14% today after the company decided to keep its annual profit forecast unchanged despite a record fiscal Q1 2024 quarter. The company's 2022 earnings rose 44.2%, compared to 76% growth in the current year. .

Net revenue: $20.6 million vs. $19.2 million forecast and $10,7 million in Q1 2023 (FactSet, 96% y/y growth)

GAAP Earnings per share (EPS) : $0.18 vs. $0.16 forecasts (FactSet, 260% y/y increase) ($4,7 million vs $589k in Q1 2023)

  • For the fiscal year ending May 31, the company maintained its previous estimate of $100 million in revenue, or 50% growth, and 90% growth in net income ($28 million GAAP). It is worth noting that the first fiscal quarter for the company (Q3) seasonally has been the weakest for the company so far, and even so, the latter - turned out to be a record in terms of net profits. 
  • However, over the horizon of the next five years, analysts expect this rate to decline to an average of 20%. The rapid appreciation of the company's shares has resulted in relatively high valuation multiples such as P/B (16), P/E (77) and P/S (15). The company will not present its next financial report until January 4, 2024.
  • Aehr makes semiconductor test and reliability qualification equipment such us burn-in of silicon-carbide power chips, mostly for electric vehicles. The company Aehr provides test and analysis to idenfytify potential defects and risks. Aehr provides also testing tools for solar energy-related technologies.

Shares of Aehr Test Systems (AEHR.US) retreated below the SMA200 (red line) today - but demand quickly lifted the stock from the $36 area, helped by a broader improvement in Wall Street sentiments. Source: xStation5

16 āļĄāļāļĢāļēāļ„āļĄ 2026, 20:00

āđ‚āļ­āļāļēāļŠāļŠāļļāļ”āļ—āđ‰āļēāļĒ āļŠāļģāļŦāļĢāļąāļšāļœāļđāđ‰āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩāđƒāļŦāļĄāđˆ

16 āļĄāļāļĢāļēāļ„āļĄ 2026, 17:37

āļ‚āđ‰āļ­āļ•āļāļĨāļ‡āļāļēāļĢāļ„āđ‰āļēāļˆāļĩāļ™â€“āđāļ„āļ™āļēāļ”āļē: āļĄāļĩāļœāļĨāļāļĢāļ°āļ—āļšāļ­āļĒāđˆāļēāļ‡āđ„āļĢāļ•āđˆāļ­āļ•āļĨāļēāļ”?

16 āļĄāļāļĢāļēāļ„āļĄ 2026, 09:24

📈 āļ„āļ§āļēāļĄāļ•āļ·āđˆāļ™āļ•āļąāļ§āđƒāļ™āļŦāļļāđ‰āļ™āđ€āļ‹āļĄāļīāļ„āļ­āļ™āļ”āļąāļāđ€āļ•āļ­āļĢāđŒ KLA Corp āļžāļļāđˆāļ‡āđāļ•āļ°āļĢāļ°āļ”āļąāļšāļŠāļđāļ‡āļŠāļļāļ”āđ€āļ›āđ‡āļ™āļ›āļĢāļ°āļ§āļąāļ•āļīāļāļēāļĢāļ“āđŒ

16 āļĄāļāļĢāļēāļ„āļĄ 2026, 08:44

💊 āļĒāļēāđƒāļŦāļĄāđˆāļ‚āļ­āļ‡ Disc Medicine āļ–āļđāļāļĢāļ°āļ‡āļąāļšāļŠāļąāđˆāļ§āļ„āļĢāļēāļ§â“

āđ€āļ‚āđ‰āļēāļŠāļđāđˆāļ•āļĨāļēāļ”āļžāļĢāđ‰āļ­āļĄāļĨāļđāļāļ„āđ‰āļēāļ‚āļ­āļ‡ XTB Group āļāļ§āđˆāļē 2 000 000 āļĢāļēāļĒ

āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ—āļĩāđˆāđ€āļĢāļēāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡ āđ€āļĻāļĐāļŦāļļāđ‰āļ™ (Fractional Shares) āđ€āļ›āđ‡āļ™āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļĩāđˆāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļˆāļēāļ XTB āđāļŠāļ”āļ‡āļ–āļķāļ‡āļāļēāļĢāđ€āļ›āđ‡āļ™āđ€āļˆāđ‰āļēāļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļšāļēāļ‡āļŠāđˆāļ§āļ™āļŦāļĢāļ·āļ­ ETF āđ€āļĻāļĐāļŦāļļāđ‰āļ™āđ„āļĄāđˆāđƒāļŠāđˆāļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ­āļīāļŠāļĢāļ° āļŠāļīāļ—āļ˜āļīāļ‚āļ­āļ‡āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ­āļēāļˆāļ–āļđāļāļˆāļģāļāļąāļ”
āļ„āļ§āļēāļĄāļŠāļđāļāđ€āļŠāļĩāļĒāļŠāļēāļĄāļēāļĢāļ–āđ€āļāļīāļ™āļāļ§āđˆāļēāđ€āļ‡āļīāļ™āļ—āļĩāđˆāļāļēāļ